Beth Israel Deaconess Medical Center KS121 is a clinical research site located in Brookline, Massachusetts, United States 02215.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
Beth Israel Deaconess Medical Center KS121 has participated in 1 clinical trials.
Therapeutic areas: Acute Myelogenous Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Graft vs. Host Disease (GvHD).
Sponsors: Genzyme, a Sanofi Company.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Massachusetts · View every site in Brookline
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Beth Israel Deaconess Medical Center KS121 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Beth Israel Deaconess Medical Center KS121 has 1 clinical trials on record. Their work covers Acute Myelogenous Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Graft vs. Host Disease (GvHD).
Beth Israel Deaconess Medical Center KS121 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.